Actively Recruiting

Age: 18Years +
All Genders
ID07511829

WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment

Led by University of Oxford · Updated on 2026-04-06

80

Participants Needed

1

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cancer treatments like chemotherapy can harm healthy cells, leading to side effects such as anemia. Anemia may cause severe tiredness, shortness of breath, and brain fog, often requiring regular blood transfusions. Patients undergoing treatment frequently experience poor quality of life due to these side effects. Doctors currently use blood tests to determine when patients can start or continue treatment, but these tests do not always reflect how patients actually feel. This research aims to better understand patients' experiences during treatment and improve how blood transfusions are used to support their quality of life. Participants in this study will include 80 adults starting treatment for blood cancers such as Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), and myeloma. They will wear a device called the Axvitiy Ax3 accelerometer for two months to monitor their physical activity levels. Alongside this, participants will complete questionnaires about their symptoms and quality of life. Family members and carers may also be invited to interviews to share their perspectives on improving care and access to transfusions. During the study, researchers will compare physical activity data with patients' reported well-being and blood test results to find better ways to match transfusion support to individual needs. This personalized approach aims to help patients tolerate treatment more effectively. The study will involve ongoing assessments over two months, including activity monitoring and quality of life questionnaires, to gather comprehensive information about the impact of low blood counts and transfusions on patients' lives.

CONDITIONS

Brief Title

WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 years or older with WHO-defined Myelodysplastic Syndrome (MDS), mixed myeloproliferative/myelodysplastic neoplasm overlap syndromes, myeloma, or Acute Myeloid Leukemia (AML)
  • Intention to start disease-modifying treatment
  • Life expectancy of 6 months or more
  • Ability to complete quality of life questionnaires
  • Willingness and ability to provide informed consent for participation
  • Willingness to receive blood products as part of normal NHS care
Not Eligible

You will not qualify if you...

  • Poor functional status (ECOG score 3 or higher)
  • Known arrhythmias or significant heart conduction disorders
  • Severe other health conditions (comorbidities)
  • Known skin allergies or conditions that may affect safety or data quality
  • Current hospitalization
  • Participation in another interventional clinical study
  • Presence of a pacemaker, implanted cardioverter defibrillator, or any cardiac implanted device

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - 2 months

Participants wear the Axvitiy Ax3 accelerometer device to collect health data related to their activity.

Participants wear the device continuously during this period; specific visit schedule not defined

Trial Site Locations

Total: 1 location

1

Oxford University Hospitals NHS Trust

Oxford, OXFORDSHIRE, United Kingdom, OX39DU

Actively Recruiting

Loading map...

Research Team

M

Matthew H Poynton, MBBS

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

A First-in-Human Study of HLA-Partially to Fully Matched All...

Acute Leukemia

Actively Recruiting

9 locations

A Platform Protocol to Investigate Post-Transplant Cyclophos...

AML (Acute Myelogenous Leukemia)

Actively Recruiting

13 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here